Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

The association between physical function and proximity to death in older adults: a multilevel analysis of 4,150 decedents from the Cardiovascular Health Study.

Karunananthan S, Moodie EEM, Bergman H, Payette H, Wolfson D, Diehr PH, Wolfson C.

Ann Epidemiol. 2019 Apr 18. pii: S1047-2797(18)31020-2. doi: 10.1016/j.annepidem.2019.04.005. [Epub ahead of print]

PMID:
31221508
2.

Normative comparison standards for measures of cognition in the Canadian Longitudinal Study on Aging (CLSA): Does applying sample weights make a difference?

O'Connell ME, Tuokko H, Kadlec H, Griffith LE, Simard M, Taler V, Voll S, Thompson ME, Panyavin I, Wolfson C, Kirkland S, Raina P.

Psychol Assess. 2019 May 27. doi: 10.1037/pas0000730. [Epub ahead of print]

PMID:
31135167
3.

The Canadian longitudinal study on aging as a platform for exploring cognition in an aging population.

Tuokko H, Griffith LE, Simard M, Taler V, O'Connell ME, Voll S, Kadlec H, Wolfson C, Kirkland S, Raina P.

Clin Neuropsychol. 2019 Jan 13:1-30. doi: 10.1080/13854046.2018.1551575. [Epub ahead of print]

PMID:
30638131
4.

Risk factors for possible REM sleep behavior disorder: A CLSA population-based cohort study.

Yao C, Fereshtehnejad SM, Keezer MR, Wolfson C, Pelletier A, Postuma RB.

Neurology. 2018 Dec 26. pii: 10.1212/WNL.0000000000006849. doi: 10.1212/WNL.0000000000006849. [Epub ahead of print]

PMID:
30587514
5.

Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.

Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C.

Int J Epidemiol. 2018 Dec 18. doi: 10.1093/ije/dyy269. [Epub ahead of print]

PMID:
30561654
6.

Validity and Reliability of a Short Diet Questionnaire to Estimate Dietary Intake in Older Adults in a Subsample of the Canadian Longitudinal Study on Aging.

Gilsing A, Mayhew AJ, Payette H, Shatenstein B, Kirkpatrick SI, Amog K, Wolfson C, Kirkland S, Griffith LE, Raina P.

Nutrients. 2018 Oct 17;10(10). pii: E1522. doi: 10.3390/nu10101522.

7.

High burden of neurological disease in the older general population: results from the Canadian Longitudinal Study on Aging.

Wolfson C, Fereshtehnejad SM, Pasquet R, Postuma R, Keezer MR.

Eur J Neurol. 2019 Feb;26(2):356-362. doi: 10.1111/ene.13823. Epub 2018 Oct 31.

PMID:
30300458
8.

Screening and treatment of hypertension in older adults: less is more?

Anker D, Santos-Eggimann B, Santschi V, Del Giovane C, Wolfson C, Streit S, Rodondi N, Chiolero A.

Public Health Rev. 2018 Sep 3;39:26. doi: 10.1186/s40985-018-0101-z. eCollection 2018. Review.

9.

A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit.

Magalhaes S, Banwell B, Bar-Or A, Fortier I, Hanwell HE, Lim M, Matt GE, Neuteboom RF, O'Riordan DL, Schneider PK, Pugliatti M, Shatenstein B, Tansey CM, Wassmer E, Wolfson C.

Mult Scler. 2019 Jul;25(8):1170-1177. doi: 10.1177/1352458518783345. Epub 2018 Jun 22.

PMID:
29932341
10.

Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis.

Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, Leung S, Fiest KM, McKay KA, Fisk JD; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2018 Mar-Apr;20(2):76-84. doi: 10.7224/1537-2073.2016-110.

11.

Miami Prospective Memory Test in the Canadian Longitudinal Study on Aging.

Simard M, Rouleau I, Kadlec H, Taler V, Tuokko H, Voll S, O'Connell ME, Griffith LE, Wolfson C, Kirkland S, Raina P.

Clin Neuropsychol. 2019 Jan;33(1):137-165. doi: 10.1080/13854046.2018.1435824. Epub 2018 Feb 12.

PMID:
29431015
12.

Effects of physical comorbidities on disability progression in multiple sclerosis.

Zhang T, Tremlett H, Zhu F, Kingwell E, Fisk JD, Bhan V, Campbell T, Stadnyk K, Carruthers R, Wolfson C, Warren S, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2018 Jan 30;90(5):e419-e427. doi: 10.1212/WNL.0000000000004885. Epub 2018 Jan 3.

13.

An evidence-based approach to the creation of normative data: base rates of impaired scores within a brief neuropsychological battery argue for age corrections, but against corrections for medical conditions.

O'Connell ME, Tuokko H, Voll S, Simard M, Griffith LE, Taler V, Wolfson C, Kirkland S, Raina P.

Clin Neuropsychol. 2017 Aug - Oct;31(6-7):1188-1203. doi: 10.1080/13854046.2017.1349931. Epub 2017 Jul 5. Erratum in: Clin Neuropsychol. 2017 Aug - Oct;31(6-7):iii.

PMID:
28679302
14.

The relation between DNA methylation patterns and serum cytokine levels in community-dwelling adults: a preliminary study.

Verschoor CP, McEwen LM, Kohli V, Wolfson C, Bowdish DM, Raina P, Kobor MS, Balion C.

BMC Genet. 2017 Jun 21;18(1):57. doi: 10.1186/s12863-017-0525-3.

15.

Increased incidence and prevalence of psoriasis in multiple sclerosis.

Marrie RA, Patten SB, Tremlett H, Wolfson C, Leung S, Fisk JD.

Mult Scler Relat Disord. 2017 Apr;13:81-86. doi: 10.1016/j.msard.2017.02.012. Epub 2017 Feb 20.

16.

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.

Mult Scler. 2018 Feb;24(2):150-157. doi: 10.1177/1352458517694088. Epub 2017 Feb 1.

PMID:
28273774
17.

Comparison of Standardization Methods for the Harmonization of Phenotype Data: An Application to Cognitive Measures.

Griffith LE, van den Heuvel E, Raina P, Fortier I, Sohel N, Hofer SM, Payette H, Wolfson C, Belleville S, Kenny M, Doiron D.

Am J Epidemiol. 2016 Nov 15;184(10):770-778. doi: 10.1093/aje/kww098.

18.

Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.

Marrie RA, Patten SB, Greenfield J, Svenson LW, Jette N, Tremlett H, Wolfson C, Warren S, Profetto-McGrath J, Fisk JD; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis, Blanchard J, Caetano P, Elliott L, Yu BN, Bhan V, Svenson L.

Brain Behav. 2016 Jun 29;6(9):e00493. eCollection 2016 Sep.

19.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872
20.

Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.

Marrie RA, Patten S, Tremlett H, Svenson LW, Wolfson C, Yu BN, Elliott L, Profetto-McGrath J, Warren S, Leung S, Jette N, Bhan V, Fisk JD.

Mult Scler Relat Disord. 2016 Jul;8:86-92. doi: 10.1016/j.msard.2016.05.009. Epub 2016 May 11.

21.

Fatigue and Comorbidities in Multiple Sclerosis.

Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, McKay KA, Berrigan LI, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2016 Mar-Apr;18(2):96-104. doi: 10.7224/1537-2073.2015-070.

22.

Differing trends in the incidence of vascular comorbidity in MS and the general population.

Marrie RA, Fisk J, Tremlett H, Wolfson C, Warren S, Blanchard J, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurol Clin Pract. 2016 Apr;6(2):120-128.

23.

Age, Gender, Comorbidity, and the MDS-UPDRS: Results from a Population-Based Study.

Keezer MR, Wolfson C, Postuma RB.

Neuroepidemiology. 2016;46(3):222-7. doi: 10.1159/000444021. Epub 2016 Mar 12.

PMID:
26967747
24.

Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.

Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, Fiest KM, McKay KA, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Neurology. 2016 Apr 12;86(15):1417-1424. doi: 10.1212/WNL.0000000000002564. Epub 2016 Mar 9.

25.

Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.

Marrie RA, Patten SB, Tremlett H, Wolfson C, Warren S, Svenson LW, Jette N, Fisk J; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2016 Apr 5;86(14):1279-1286. doi: 10.1212/WNL.0000000000002481. Epub 2016 Mar 9.

26.

Differences in the burden of psychiatric comorbidity in MS vs the general population.

Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2015 Dec 1;85(22):1972-9. doi: 10.1212/WNL.0000000000002174. Epub 2015 Oct 30.

27.

Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.

Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C.

Eur J Neurol. 2016 Jan;23(1):168-74. doi: 10.1111/ene.12830. Epub 2015 Oct 16.

PMID:
26475404
28.

Observational Study of the Relation between Parkinson's Disease and Sleep Apnea.

Béland SG, Postuma RB, Latreille V, Bertrand JA, Panisset M, Chouinard S, Wolfson C, Gagnon JF.

J Parkinsons Dis. 2015;5(4):805-11. doi: 10.3233/JPD-150602.

PMID:
26407040
29.

Comorbidity is associated with pain-related activity limitations in multiple sclerosis.

Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, McKay KA, Berrigan L, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Mult Scler Relat Disord. 2015 Sep;4(5):470-476. doi: 10.1016/j.msard.2015.07.014. Epub 2015 Jul 29.

30.

Mining a Unique Canadian Resource: The Canadian Longitudinal Study on Aging.

Kirkland SA, Griffith LE, Menec V, Wister A, Payette H, Wolfson C, Raina PS.

Can J Aging. 2015 Sep;34(3):366-77. doi: 10.1017/S071498081500029X. No abstract available.

PMID:
26300192
31.

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).

Kingwell E, Zhu F, Marrie RA, Fisk JD, Wolfson C, Warren S, Profetto-McGrath J, Svenson LW, Jette N, Bhan V, Yu BN, Elliott L, Tremlett H.

J Neurol. 2015 Oct;262(10):2352-63. doi: 10.1007/s00415-015-7842-0. Epub 2015 Jul 24.

32.

General Practitioner Preferences in Managing Care of Multiple Sclerosis Patients.

Bray M, Wolfson C, Moore F, Zhu B, Uniat J.

Can J Neurol Sci. 2016 Jan;43(1):142-8. doi: 10.1017/cjn.2015.239. Epub 2015 Jul 1.

PMID:
26132320
33.

The diagnostic accuracy of routine electroencephalography after a first unprovoked seizure.

Bouma HK, Labos C, Gore GC, Wolfson C, Keezer MR.

Eur J Neurol. 2016 Mar;23(3):455-63. doi: 10.1111/ene.12739. Epub 2015 Jun 13. Review.

PMID:
26073548
34.

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M.

Mult Scler. 2016 Jan;22(1):104-11. doi: 10.1177/1352458515579444. Epub 2015 May 26.

35.

The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C.

Neuroepidemiology. 2015;44(3):173-81. doi: 10.1159/000381779. Epub 2015 May 7.

36.

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2015 Dec;21(14):1856-64. doi: 10.1177/1352458515578770. Epub 2015 May 6.

37.

Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study.

Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM, Wolfson C, Pugliatti M.

J Neurol. 2015 May;262(5):1271-7. doi: 10.1007/s00415-015-7704-9. Epub 2015 Mar 21.

PMID:
25794863
38.

Erratum to: Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.

Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A, Arnulf I, Högl B, Manni R, Miyamoto T, Fantini ML, Puligheddu M, Jennum P, Sonka K, Santamaria J, Zucconi M, Rancoita PM, Leu-Semenescu S, Frauscher B, Terzaghi M, Miyamoto M, Unger M, Stiasny-Kolster K, Desautels A, Wolfson C, Pelletier A, Montplaisir J.

J Neurol. 2015 Jan;262(1):249-50. doi: 10.1007/s00415-014-7609-z. No abstract available.

PMID:
25504448
39.

Statistical approaches to harmonize data on cognitive measures in systematic reviews are rarely reported.

Griffith LE, van den Heuvel E, Fortier I, Sohel N, Hofer SM, Payette H, Wolfson C, Belleville S, Kenny M, Doiron D, Raina P.

J Clin Epidemiol. 2015 Feb;68(2):154-62. doi: 10.1016/j.jclinepi.2014.09.003. Epub 2014 Dec 8.

40.

The diagnostic accuracy of screening questionnaires for the identification of adults with epilepsy: a systematic review.

Keezer MR, Bouma HK, Wolfson C.

Epilepsia. 2014 Nov;55(11):1772-80. doi: 10.1111/epi.12811. Epub 2014 Nov 6. Review.

41.

Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review.

Goulden R, Ibrahim T, Wolfson C.

Eur J Neurol. 2015 Jun;22(6):899-911. doi: 10.1111/ene.12586. Epub 2014 Nov 5. Review.

PMID:
25370720
42.

The diagnostic test accuracy of a screening questionnaire and algorithm in the identification of adults with epilepsy.

Keezer MR, Pelletier A, Stechysin B, Veilleux M, Jetté N, Wolfson C.

Epilepsia. 2014 Nov;55(11):1763-71. doi: 10.1111/epi.12805. Epub 2014 Oct 13.

43.

Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study.

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM.

Mult Scler. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785. Epub 2014 Sep 2.

PMID:
25182290
44.

Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia.

Marrie RA, Fisk JD, Stadnyk KJ, Tremlett H, Wolfson C, Warren S, Bhan V, Yu BN; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Chronic Dis Inj Can. 2014 Jul;34(2-3):145-53. English, French.

45.

Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.

Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A, Arnulf I, Högl B, Manni R, Miyamoto T, Fantini ML, Puligheddu M, Jennum P, Sonka K, Santamaria J, Zucconi M, Rancoita PM, Leu-Semenescu S, Frauscher B, Terzaghi M, Miyamoto M, Unger M, Stiasny-Kolster K, Desautels A, Wolfson C, Pelletier A, Montplaisir J.

J Neurol. 2014 Jun;261(6):1112-8. doi: 10.1007/s00415-014-7317-8. Epub 2014 Apr 1. Erratum in: J Neurol. 2015 Jan;262(1):249-50. Birgit, Högl [corrected to Högl, Birgit].

PMID:
24687894
46.

Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study.

Frauscher B, Jennum P, Ju YE, Postuma RB, Arnulf I, Cochen De Cock V, Dauvilliers Y, Fantini ML, Ferini-Strambi L, Gabelia D, Iranzo A, Leu-Semenescu S, Mitterling T, Miyamoto M, Miyamoto T, Montplaisir JY, Oertel W, Pelletier A, Prunetti P, Puligheddu M, Santamaria J, Sonka K, Unger M, Wolfson C, Zucconi M, Terzaghi M, Högl B, Mayer G, Manni R.

Neurology. 2014 Mar 25;82(12):1076-9. doi: 10.1212/WNL.0000000000000247. Epub 2014 Feb 19.

47.

The relationship of self-rated health with functional status, toxicity and mortality: results of a prospective pilot study of older patients with newly-diagnosed cancer.

Puts M, Monette J, Girre V, Sourial N, Wolfson C, Monette M, Batist G, Bergman H.

J Geriatr Oncol. 2013 Oct;4(4):319-26. doi: 10.1016/j.jgo.2013.07.003. Epub 2013 Aug 12.

PMID:
24472474
48.

Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study.

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M.

Mult Scler. 2014 Jul;20(8):1042-9. doi: 10.1177/1352458513513968. Epub 2014 Jan 10.

PMID:
24414538
49.

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review.

Makhani N, Morrow SA, Fisk J, Evans C, Beland SG, Kulaga S, Kingwell E, Marriott JJ, Dykeman J, Jetté N, Pringsheim T, Wolfson C, Marrie RA, Koch MW.

Mult Scler Relat Disord. 2014 Jan;3(1):48-60. doi: 10.1016/j.msard.2013.06.015. Epub 2013 Jul 25.

PMID:
25877973
50.

The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada.

Marrie RA, Fisk JD, Stadnyk KJ, Yu BN, Tremlett H, Wolfson C, Warren S, Bhan V; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Can J Neurol Sci. 2013 Nov;40(6):824-31.

PMID:
24257224

Supplemental Content

Loading ...
Support Center